Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
11-Sep-2020
Corporate Presentation for ShareCafe Hidden Gems Webinar
9-Sep-2020
Nyrada Investor Webinar
8-Sep-2020
Initial Director's Interest Notice - ID
8-Sep-2020
Final Director's Interest Notice - GK
8-Sep-2020
Annual Report to 30 June 2020
8-Sep-2020
Appendix 4G and Corporate Governance Statement
31-Aug-2020
FY 2020 Appendix 4E Preliminary Financial Report
31-Aug-2020
Nyrada Board Changes
30-Jul-2020
Nyrada Global Webcast Invitation
29-Jul-2020
Nyrada A$1.0M R&D Tax Rebate & Use of Funds Annexure
Previous
1
2
3
4
5
6
7
8
Next
